Hisashi Wada

Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

Takuro Saito, Hiroyoshi Nishikawa, Hisashi Wada et al. · Nature Medicine · 2016 · 885 citations

Medicine, Immunology, Oncology +12

Characterization of tumor necrosis factor-deficient mice

Michael W. Marino, Ashley R. Dunn, Dianne Grail et al. · Proceedings of the National Academy of Sciences · 1997 · 793 citations

Life Sciences, Immunology, Pathology +17

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

Elke Jäger, Yao-Tseng Chen, Jan W. Drijfhout et al. · The Journal of Experimental Medicine · 1998 · 725 citations · Full text

Life Sciences, Immunology, Oncology +17

Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

Elke Jäger, Yasuhiro Nagata, Sacha Gnjatic et al. · Proceedings of the National Academy of Sciences · 2000 · 398 citations

Life Sciences, Immunology, Oncology +17

Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients

Koji Kurose, Yoshihiro Ohue, Hisashi Wada et al. · Clinical Cancer Research · 2015 · 254 citations

Medicine, Immunology, Oncology +16